These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 16255628

  • 1. Liquid-based cytology for cervical cancer screening.
    Bentz JS.
    Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi.
    Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ.
    Cytopathology; 2006 Dec; 17(6):374-81. PubMed ID: 17168921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
    Laiwejpithaya S, Benjapibal M, Laiwejpithaya S, Wongtiraporn W, Sangkarat S, Rattanachaiyanont M.
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
    [Abstract] [Full Text] [Related]

  • 9. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
    Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.
    Vaccine; 2006 Aug 31; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
    [Abstract] [Full Text] [Related]

  • 10. Cervical cancer screening in the early post vaccine era.
    Waxman AG.
    Obstet Gynecol Clin North Am; 2008 Dec 31; 35(4):537-48; vii. PubMed ID: 19061815
    [Abstract] [Full Text] [Related]

  • 11. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
    Park J, Jung EH, Kim C, Choi YH.
    Diagn Cytopathol; 2007 Aug 31; 35(8):488-92. PubMed ID: 17636495
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Two cytological methods for screening for cervical cancer].
    Kirschner B, Simonsen K, Junge J.
    Ugeskr Laeger; 2008 May 26; 170(22):1933-7. PubMed ID: 18513478
    [Abstract] [Full Text] [Related]

  • 14. Advances in cervical screening technology.
    Stoler MH.
    Mod Pathol; 2000 Mar 26; 13(3):275-84. PubMed ID: 10757338
    [Abstract] [Full Text] [Related]

  • 15. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry.
    Narimatsu R, Patterson BK.
    Am J Clin Pathol; 2005 May 26; 123(5):716-23. PubMed ID: 15981811
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.
    J Low Genit Tract Dis; 2007 Oct 26; 11(4):258-64. PubMed ID: 17917570
    [Abstract] [Full Text] [Related]

  • 17. Dutch solutions for liquid-based cytology: analysis of unsatisfactory slides and HPV testing of equivocal cytology.
    Boon ME, Rijkaart DC, Ouwerkerk-Noordam E, Korporaal H.
    Diagn Cytopathol; 2006 Sep 26; 34(9):644-8. PubMed ID: 16900471
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus testing for primary cervical cancer screening.
    Grce M, Davies P.
    Expert Rev Mol Diagn; 2008 Sep 26; 8(5):599-605. PubMed ID: 18785808
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M, Marino J, Griffin B, Spencer L, Bolick D.
    Cancer; 2004 Oct 25; 102(5):269-79. PubMed ID: 15386329
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.